Dynamic Technology Lab Private LTD Concert Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $28,763 - $41,511	-10,536 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $28,341 - $44,461	10,536 New	10,536 $33,000
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $135,558 - $189,063	-10,574 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $177,960 - $229,032	10,574 New	10,574 $178,000
Q1 2018 May 14, 2018	SELL	$19.24 - $28.03 $1.23 Million - $1.79 Million	-63,974 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$13.96 - $29.05 $893,077 - $1.86 Million	63,974	63,974 $1.66 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.